Literature DB >> 16893192

Catalysis of covalent Lp(a) assembly: evidence for an extracellular enzyme activity that enhances disulfide bond formation.

Lev Becker1, Michael E Nesheim, Marlys L Koschinsky.   

Abstract

The assembly of lipoprotein(a) (Lp(a)) particles occurs via a two-step mechanism in which noncovalent interactions between apolipoprotein(a) (apo(a)) and the apolipoproteinB-100 component of low density lipoprotein precede the formation of a single disulfide bond. Although we have previously demonstrated that the rate constant for the covalent step of Lp(a) assembly can be enhanced by altering the conformational status of apo(a), the resultant rates of covalent Lp(a) particle formation measured in vitro are relatively slow. The large excess of Lp(a) (over apo(a)) observed in vivo can be accounted for by a preferential clearance of apo(a) over Lp(a) and/or a sufficiently high rate of covalent Lp(a) assembly. In the present study, we report that cultured human hepatoma cells secrete an oxidase activity that dramatically enhances the rate of covalent Lp(a) assembly. This activity is likely possessed by a protein because it is heat-sensitive and is retained in the concentrate following ultrafiltration through a 5 kDa cutoff filter. However, a small molecule cofactor for the activity is suggested by the observation that the activity is lost upon dialysis. Plots of Lp(a) assembly rate versus input apo(a) concentration gave rectangular hyperbolae; the reaction displayed an unusual dependence on the concentration of apoB-100, with increasing concentrations of apoB-100 resulting in slower rates of Lp(a) assembly at low concentrations of apo(a), an effect that was alleviated by higher apo(a) concentrations. Interestingly, V(max(app))/K(m(app)) ratios were insensitive to apoB-100 concentration, which is diagnostic of a ping-pong reaction mechanism. In this way, the putative Lp(a) oxidase may be functionally analogous to protein disulfide isomerase, which exhibits a similar mechanism during the catalysis of disulfide bond formation during protein folding, although we have ruled out a role for this enzyme in Lp(a) assembly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893192     DOI: 10.1021/bi060283t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

Review 1.  Update on lipoprotein(a) as a cardiovascular risk factor and mediator.

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

2.  Locations of the beta1 transmembrane helices in the BK potassium channel.

Authors:  Guoxia Liu; Sergey I Zakharov; Lin Yang; Roland S Wu; Shi-Xian Deng; Donald W Landry; Arthur Karlin; Steven O Marx
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

3.  Position and role of the BK channel alpha subunit S0 helix inferred from disulfide crosslinking.

Authors:  Guoxia Liu; Sergey I Zakharov; Lin Yang; Shi-Xian Deng; Donald W Landry; Arthur Karlin; Steven O Marx
Journal:  J Gen Physiol       Date:  2008-05-12       Impact factor: 4.086

4.  Nicotinic acid inhibits hepatic APOA gene expression: studies in humans and in transgenic mice.

Authors:  Indumathi Chennamsetty; Karam M Kostner; Thierry Claudel; Manjula Vinod; Sasa Frank; Thomas S Weiss; Michael Trauner; Gerhard M Kostner
Journal:  J Lipid Res       Date:  2012-08-28       Impact factor: 5.922

5.  Location of modulatory beta subunits in BK potassium channels.

Authors:  Guoxia Liu; Xiaowei Niu; Roland S Wu; Neelesh Chudasama; Yongneng Yao; Xin Jin; Richard Weinberg; Sergey I Zakharov; Howard Motoike; Steven O Marx; Arthur Karlin
Journal:  J Gen Physiol       Date:  2010-04-12       Impact factor: 4.086

6.  Location of the beta 4 transmembrane helices in the BK potassium channel.

Authors:  Roland S Wu; Neelesh Chudasama; Sergey I Zakharov; Darshan Doshi; Howard Motoike; Guoxia Liu; Yongneng Yao; Xiaowei Niu; Shi-Xian Deng; Donald W Landry; Arthur Karlin; Steven O Marx
Journal:  J Neurosci       Date:  2009-07-01       Impact factor: 6.167

Review 7.  Elevated Lipoprotein(a): Background, Current Insights and Future Potential Therapies.

Authors:  Ahmed Handhle; Adie Viljoen; Anthony S Wierzbicki
Journal:  Vasc Health Risk Manag       Date:  2021-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.